Invitation | EClinCloud invites you to the 2024 China (Ningbo) Biopharmaceutical Industry Development Conference

Source: EClinCloud. Author: EClinCloud.
Click the image above to view the full conference agenda
The 3rd China (Ningbo) Biopharmaceutical Industry Development Conference will be held from November 22 to 23 in Ningbo Qianwan New Area. The conference will focus on themes including R&D innovation and international cooperation: in R&D innovation, it will pay particular attention to areas such as metabolic and obesity-related diseases and immune system diseases; in business cooperation, it will feature in-depth discussions on key topics such as innovative drug investment and financing and the NewCo model.
During the conference, the EClinCloud team will host an exhibition booth on site to share achievements in supporting clinical research with digital and intelligent technologies with industry colleagues, and we look forward to welcoming you for discussions.
EClinCloud Booth Location:
We look forward to welcoming you for discussions!

Visit our booth for an interactive prize draw
100% win rate!

EClinCloud looks forward to seeing you there
Conference Details
Conference Dates: November 22–23, 2024
Conference Venue: Hyatt Regency Ningbo Hangzhou Bay
*Click "Read Original" at the end of the article to view the full conference agenda and register
EClinCloud is a technology company focused on clinical R&D. It provides an integrated, interconnected all-in-one clinical trial cloud platform (including solutions such as scale design, scale copyright management, linguistic validation, rater training, and data quality analysis across technology products and solutions including eCOA, CTMS, eTMF, EDC, RTSM, and RM) as well as clinical trial endpoint assessment technologies across therapeutic areas (including central nervous system, ophthalmology, and others). By combining cutting-edge technology with life sciences data, it builds a globally leading, "patient-centric" SaaS cloud platform for clinical evidence support to help domestic and international pharmaceutical companies and research institutions improve R&D efficiency, accelerate the market launch of drugs and devices, and benefit countless patients.



